Find a Clinical Trial
Filter
Takeda footprint
Neonatal care
All genders
Recruiting now
Department of Obstetrics + Gynecology
Tufts Medical Center
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Breast cancer, Locally advanced and metastatic breast cancer
All genders
Recruiting now
Cancer Center
Tufts Medical Center
BoppliTM blood pressure monitoring
Neonatal care
All genders
Recruiting now
Department of Pediatrics
Tufts Medical Center
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
Tufts Medical Center
Body composition in VLBW infants
All genders
No minimum age
Recruiting now
Department of Pediatrics
Tufts Medical Center
Breast Cancer Database
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Tufts Medical Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
Recruiting now
Cancer Center
Tufts Medical Center
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
Recruiting now
Cancer Center
Tufts Medical Center
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Tufts Medical Center
HER2 Negative Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Tufts Medical Center